Vicarious Surgical (RBOT) Long-Term Deferred Tax (2020 - 2021)
Vicarious Surgical's (RBOT) quarterly Long-Term Deferred Tax came in at $22.8 million in Q4 2021, up 153.16% year-over-year from $9.0 million in Q4 2020, and up 153.16% quarter-over-quarter from $9.0 million in Q4 2020.
Powered by 
Analysis
Vicarious Surgical (RBOT) Long-Term Deferred Tax (2020 - 2021) Analysis & Trends
Vicarious Surgical (RBOT) has reported Long-Term Deferred Tax for 2 consecutive years, with $22.8 million the latest figure, recorded in Q4 2021.
- On a quarterly basis, Long-Term Deferred Tax rose 153.16% year-over-year to $22.8 million in Q4 2021; TTM through Dec 2021 was $22.8 million, a 153.16% increase from a year earlier, with the FY2021 full-year figure at $22.8 million, up 153.16% from the prior year.
- Long-Term Deferred Tax was $22.8 million for Q4 2021 at Vicarious Surgical, up from $9.0 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $22.8 million in Q4 2021 and troughed at $9.0 million in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Vicarious Surgical | 231,626.35 | -14.81 Mn | - |